Xoma files against Biosite Diagnostics:
This article was originally published in Clinica
Biopharmaceutical company Xoma has filed a complaint against Biosite Diagnostics alleging infringement of its bacterial cell expression technology patents in connection with some of Biosite's technologies and collaborations. Berkeley, California-based Xoma is seeking an injunction and damages for fraud and misrepresentation, breach of contract, misappropriation and unfair business practices. It has also filed a motion to dismiss a declaratory judgement action filed by Biosite.